| 0 |
HUMAN ANTICHIMERIC ANTIBODY POSITIVE |
302 |
0.8988 |
| 1 |
INFILTRATION ANAESTHESIA |
22 |
0.6875 |
| 2 |
ACTINOMYCOTIC SEPSIS |
17 |
0.6800 |
| 3 |
HUMAN ANTI-HUMAN ANTIBODY TEST |
16 |
0.5926 |
| 4 |
BODY HEIGHT BELOW NORMAL |
312 |
0.4852 |
| 5 |
LUNG DISEASE INFECTIVE EXACERBATION |
10 |
0.3704 |
| 6 |
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME |
11 |
0.3548 |
| 7 |
ALPHA TUMOUR NECROSIS FACTOR INCREASED |
30 |
0.3226 |
| 8 |
SERUM AMYLOID A PROTEIN INCREASED |
46 |
0.2968 |
| 9 |
AUTOINFLAMMATORY DISEASE |
58 |
0.2736 |
| 10 |
ANKLE ARTHROPLASTY |
96 |
0.2645 |
| 11 |
TUMOUR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME |
15 |
0.2500 |
| 12 |
SHORT STATURE |
59 |
0.2252 |
| 13 |
INTESTINAL SEPSIS |
51 |
0.1947 |
| 14 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
423 |
0.1834 |
| 15 |
JOINT DESTRUCTION |
256 |
0.1645 |
| 16 |
PROPIONIBACTERIUM INFECTION |
17 |
0.1589 |
| 17 |
SKIN GRAFT INFECTION |
10 |
0.1562 |
| 18 |
JUVENILE IDIOPATHIC ARTHRITIS |
372 |
0.1520 |
| 19 |
IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY |
26 |
0.1494 |
| 20 |
ANTIBODY TEST POSITIVE |
235 |
0.1415 |
| 21 |
INTERLEUKIN LEVEL INCREASED |
76 |
0.1377 |
| 22 |
HAIR FOLLICLE TUMOUR BENIGN |
15 |
0.1351 |
| 23 |
HEPATOSPLENIC T-CELL LYMPHOMA |
48 |
0.1294 |
| 24 |
BONE DENSITY INCREASED |
50 |
0.1253 |
| 25 |
HERPES ZOSTER INFECTION NEUROLOGICAL |
19 |
0.1195 |
| 26 |
VEXAS SYNDROME |
11 |
0.1146 |
| 27 |
AUTOIMMUNE PANCYTOPENIA |
10 |
0.1099 |
| 28 |
CRYOPYRIN ASSOCIATED PERIODIC SYNDROME |
21 |
0.1071 |
| 29 |
HYPERFERRITINAEMIA |
46 |
0.1067 |
| 30 |
BODY TINEA |
58 |
0.1036 |
| 31 |
TESTICULAR SEMINOMA (PURE) |
12 |
0.1008 |
| 32 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
725 |
0.0965 |
| 33 |
SOFT TISSUE DISORDER |
106 |
0.0956 |
| 34 |
PNEUMONIA LIPOID |
13 |
0.0949 |
| 35 |
POLYARTHRITIS |
498 |
0.0944 |
| 36 |
PARVOVIRUS INFECTION |
38 |
0.0941 |
| 37 |
APPARENT DEATH |
323 |
0.0896 |
| 38 |
DRUG SPECIFIC ANTIBODY |
120 |
0.0876 |
| 39 |
GROWTH FAILURE |
30 |
0.0872 |
| 40 |
CLUBBING |
35 |
0.0858 |
| 41 |
DIAPHRAGM MUSCLE WEAKNESS |
13 |
0.0823 |
| 42 |
FAMILIAL MEDITERRANEAN FEVER |
16 |
0.0816 |
| 43 |
EPIDURAL LIPOMATOSIS |
26 |
0.0756 |
| 44 |
POLYARTERITIS NODOSA |
44 |
0.0753 |
| 45 |
BREAST ULCERATION |
10 |
0.0719 |
| 46 |
HYPERTENSIVE CARDIOMYOPATHY |
19 |
0.0683 |
| 47 |
ORAL MUCOSAL EXFOLIATION |
103 |
0.0680 |
| 48 |
RHEUMATOID FACTOR POSITIVE |
391 |
0.0676 |
| 49 |
SPINAL CORD INJURY CERVICAL |
17 |
0.0675 |
| 50 |
IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME |
10 |
0.0662 |
| 51 |
IMMOBILISATION SYNDROME |
14 |
0.0657 |
| 52 |
VASCULITIC RASH |
48 |
0.0622 |
| 53 |
C-REACTIVE PROTEIN ABNORMAL |
398 |
0.0620 |
| 54 |
JUVENILE ARTHRITIS |
20 |
0.0610 |
| 55 |
SOFT TISSUE SWELLING |
34 |
0.0599 |
| 56 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
646 |
0.0583 |
| 57 |
COMPLICATIONS OF BONE MARROW TRANSPLANT |
21 |
0.0582 |
| 58 |
ARTHRODESIS |
57 |
0.0560 |
| 59 |
DISSEMINATED MUCORMYCOSIS |
22 |
0.0558 |
| 60 |
MENTAL DISORDER DUE TO A GENERAL MEDICAL CONDITION |
17 |
0.0543 |
| 61 |
SPLENIC ABSCESS |
22 |
0.0541 |
| 62 |
JOINT ARTHROPLASTY |
96 |
0.0536 |
| 63 |
ADRENAL SUPPRESSION |
43 |
0.0510 |
| 64 |
COLD URTICARIA |
11 |
0.0500 |
| 65 |
DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION |
11 |
0.0498 |
| 66 |
ALVEOLAR PROTEINOSIS |
28 |
0.0473 |
| 67 |
STEROID DEPENDENCE |
41 |
0.0467 |
| 68 |
SYNOVITIS |
804 |
0.0445 |
| 69 |
WHEELCHAIR USER |
195 |
0.0438 |
| 70 |
ADRENAL INSUFFICIENCY |
529 |
0.0435 |
| 71 |
CYTOMEGALOVIRUS HEPATITIS |
15 |
0.0424 |
| 72 |
EPSTEIN-BARR VIRAEMIA |
44 |
0.0397 |
| 73 |
SMEAR CERVIX ABNORMAL |
56 |
0.0394 |
| 74 |
BLOOD LACTATE DEHYDROGENASE DECREASED |
13 |
0.0390 |
| 75 |
CLEAR CELL RENAL CELL CARCINOMA |
27 |
0.0388 |
| 76 |
CONGENITAL APLASIA |
12 |
0.0386 |
| 77 |
ANKLE OPERATION |
56 |
0.0379 |
| 78 |
HISTIOCYTOSIS HAEMATOPHAGIC |
110 |
0.0370 |
| 79 |
CELLULITIS STAPHYLOCOCCAL |
24 |
0.0369 |
| 80 |
DRUG TOLERANCE |
183 |
0.0361 |
| 81 |
PNEUMONIA VIRAL |
109 |
0.0342 |
| 82 |
POST PROCEDURAL CONTUSION |
11 |
0.0335 |
| 83 |
FINE MOTOR SKILL DYSFUNCTION |
97 |
0.0335 |
| 84 |
INHIBITORY DRUG INTERACTION |
52 |
0.0328 |
| 85 |
CUTANEOUS VASCULITIS |
118 |
0.0323 |
| 86 |
FOCAL NODULAR HYPERPLASIA |
16 |
0.0308 |
| 87 |
SERUM FERRITIN INCREASED |
160 |
0.0303 |
| 88 |
OBESITY |
479 |
0.0300 |
| 89 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
213 |
0.0297 |
| 90 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
170 |
0.0287 |
| 91 |
ADENOVIRUS INFECTION |
83 |
0.0286 |
| 92 |
CONTRAINDICATED PRODUCT ADMINISTERED |
848 |
0.0280 |
| 93 |
SYSTEMIC CANDIDA |
68 |
0.0271 |
| 94 |
ACNE CYSTIC |
80 |
0.0265 |
| 95 |
CHONDROCALCINOSIS |
17 |
0.0260 |
| 96 |
INFECTION SUSCEPTIBILITY INCREASED |
57 |
0.0260 |
| 97 |
LARYNGEAL STENOSIS |
15 |
0.0260 |
| 98 |
VARICELLA ZOSTER VIRUS INFECTION |
50 |
0.0241 |
| 99 |
POLYCHONDRITIS |
10 |
0.0237 |
| 100 |
TERMINAL STATE |
154 |
0.0230 |
| 101 |
PNEUMOCYSTIS JIROVECII INFECTION |
27 |
0.0226 |
| 102 |
HYPOFIBRINOGENAEMIA |
22 |
0.0222 |
| 103 |
CUSHINGOID |
69 |
0.0215 |
| 104 |
INJECTION SITE HYPERSENSITIVITY |
66 |
0.0211 |
| 105 |
DEFORMITY |
196 |
0.0209 |
| 106 |
SPINAL STENOSIS |
85 |
0.0206 |
| 107 |
SPONDYLOARTHROPATHY |
12 |
0.0200 |
| 108 |
PULMONARY THROMBOSIS |
215 |
0.0197 |
| 109 |
MENINGITIS LISTERIA |
10 |
0.0196 |
| 110 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
28 |
0.0192 |
| 111 |
SHOULDER ARTHROPLASTY |
50 |
0.0185 |
| 112 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
39 |
0.0183 |
| 113 |
FOOT OPERATION |
89 |
0.0180 |
| 114 |
MYOPERICARDITIS |
14 |
0.0179 |
| 115 |
C-REACTIVE PROTEIN INCREASED |
649 |
0.0178 |
| 116 |
HYPERPLASIA |
16 |
0.0178 |
| 117 |
MULTIPLE-DRUG RESISTANCE |
54 |
0.0174 |
| 118 |
VIRAEMIA |
24 |
0.0173 |
| 119 |
IMMUNODEFICIENCY |
257 |
0.0172 |
| 120 |
ANAL STENOSIS |
9 |
0.0169 |
| 121 |
SERUM FERRITIN DECREASED |
29 |
0.0168 |
| 122 |
MENINGITIS VIRAL |
23 |
0.0168 |
| 123 |
HAND DEFORMITY |
216 |
0.0165 |
| 124 |
FOOT DEFORMITY |
182 |
0.0164 |
| 125 |
INFLAMMATORY MARKER INCREASED |
81 |
0.0163 |
| 126 |
WRIST DEFORMITY |
10 |
0.0163 |
| 127 |
NODULE |
210 |
0.0161 |
| 128 |
SENSITIVITY TO WEATHER CHANGE |
84 |
0.0159 |
| 129 |
GRAFT VERSUS HOST DISEASE IN SKIN |
35 |
0.0159 |
| 130 |
AMYLOIDOSIS |
27 |
0.0156 |
| 131 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
68 |
0.0154 |
| 132 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
682 |
0.0152 |
| 133 |
JOINT EFFUSION |
104 |
0.0151 |
| 134 |
DIVERTICULITIS |
414 |
0.0149 |
| 135 |
HEPATOSPLENOMEGALY |
38 |
0.0148 |
| 136 |
CHRONIC SPONTANEOUS URTICARIA |
17 |
0.0147 |
| 137 |
GRANULOMA SKIN |
12 |
0.0146 |
| 138 |
CYTOKINE STORM |
10 |
0.0146 |
| 139 |
OBLITERATIVE BRONCHIOLITIS |
19 |
0.0145 |
| 140 |
ANTINUCLEAR ANTIBODY POSITIVE |
47 |
0.0145 |
| 141 |
BRADYCARDIA FOETAL |
12 |
0.0144 |
| 142 |
SEPTIC SHOCK |
618 |
0.0142 |
| 143 |
GLUCOSE TOLERANCE IMPAIRED |
83 |
0.0140 |
| 144 |
DRUG SPECIFIC ANTIBODY PRESENT |
91 |
0.0140 |
| 145 |
RHEUMATOID ARTHRITIS |
1556 |
0.0137 |
| 146 |
INJECTION SITE URTICARIA |
335 |
0.0136 |
| 147 |
GROWTH RETARDATION |
40 |
0.0136 |
| 148 |
LOCAL REACTION |
10 |
0.0135 |
| 149 |
SERRATIA INFECTION |
10 |
0.0134 |
| 150 |
PARVOVIRUS B19 INFECTION |
12 |
0.0134 |
| 151 |
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS |
33 |
0.0133 |
| 152 |
GASTROENTERITIS VIRAL |
238 |
0.0132 |
| 153 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
35 |
0.0131 |
| 154 |
ENCEPHALITIS VIRAL |
16 |
0.0131 |
| 155 |
RENAL MASS |
27 |
0.0131 |
| 156 |
ARTHROPATHY |
728 |
0.0131 |
| 157 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
18 |
0.0131 |
| 158 |
TRANSPLANT FAILURE |
31 |
0.0126 |
| 159 |
BONE DENSITY DECREASED |
387 |
0.0123 |
| 160 |
SERONEGATIVE ARTHRITIS |
14 |
0.0122 |
| 161 |
HUMAN HERPESVIRUS 6 INFECTION |
23 |
0.0122 |
| 162 |
DRUG INTOLERANCE |
1168 |
0.0121 |
| 163 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
46 |
0.0120 |
| 164 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
11 |
0.0119 |
| 165 |
SUPERFICIAL VEIN THROMBOSIS |
10 |
0.0119 |
| 166 |
ENDODONTIC PROCEDURE |
30 |
0.0118 |
| 167 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
566 |
0.0118 |
| 168 |
CYTOMEGALOVIRUS VIRAEMIA |
52 |
0.0117 |
| 169 |
CYTOKINE RELEASE SYNDROME |
231 |
0.0115 |
| 170 |
SKIN STRIAE |
17 |
0.0114 |
| 171 |
PULMONARY FIBROSIS |
218 |
0.0114 |
| 172 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
16 |
0.0113 |
| 173 |
VARICELLA |
27 |
0.0113 |
| 174 |
MUSCULOSKELETAL DISORDER |
211 |
0.0111 |
| 175 |
INJECTION SITE RASH |
340 |
0.0111 |
| 176 |
BACTERIAL SEPSIS |
36 |
0.0110 |
| 177 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
22 |
0.0110 |
| 178 |
DISLOCATION OF VERTEBRA |
25 |
0.0110 |
| 179 |
NORMOCYTIC ANAEMIA |
16 |
0.0109 |
| 180 |
C-REACTIVE PROTEIN |
10 |
0.0108 |
| 181 |
CYTOPENIA |
130 |
0.0106 |
| 182 |
FIBROMYALGIA |
258 |
0.0106 |
| 183 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
54 |
0.0106 |
| 184 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
16 |
0.0106 |
| 185 |
HYPOCALCAEMIA |
200 |
0.0106 |
| 186 |
INFECTION REACTIVATION |
12 |
0.0105 |
| 187 |
PSEUDOMONAL SEPSIS |
18 |
0.0103 |
| 188 |
OPPORTUNISTIC INFECTION |
19 |
0.0103 |
| 189 |
INJECTION SITE INFLAMMATION |
51 |
0.0102 |
| 190 |
NEUROENDOCRINE CARCINOMA OF THE SKIN |
10 |
0.0102 |
| 191 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
28 |
0.0101 |
| 192 |
EPSTEIN-BARR VIRUS INFECTION |
62 |
0.0099 |
| 193 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
23 |
0.0099 |
| 194 |
JOINT SWELLING |
1192 |
0.0099 |
| 195 |
MENINGITIS CRYPTOCOCCAL |
17 |
0.0097 |
| 196 |
PEMPHIGUS |
121 |
0.0097 |
| 197 |
BLOOD FIBRINOGEN DECREASED |
11 |
0.0096 |
| 198 |
THERAPY NON-RESPONDER |
433 |
0.0096 |
| 199 |
DEMYELINATION |
39 |
0.0095 |
| 200 |
PAROTITIS |
11 |
0.0095 |
| 201 |
LIVER FUNCTION TEST ABNORMAL |
275 |
0.0094 |
| 202 |
ENTEROCOCCAL BACTERAEMIA |
10 |
0.0094 |
| 203 |
RHEUMATOID NODULE |
26 |
0.0094 |
| 204 |
RHEUMATIC FEVER |
42 |
0.0094 |
| 205 |
MOBILITY DECREASED |
670 |
0.0093 |
| 206 |
DRUG TOLERANCE DECREASED |
26 |
0.0092 |
| 207 |
PERICARDITIS |
154 |
0.0092 |
| 208 |
HERPES ZOSTER |
526 |
0.0091 |
| 209 |
FUNGAEMIA |
14 |
0.0089 |
| 210 |
ARTHRITIS |
699 |
0.0089 |
| 211 |
LUPUS VULGARIS |
11 |
0.0087 |
| 212 |
SECRETION DISCHARGE |
107 |
0.0085 |
| 213 |
TREATMENT FAILURE |
693 |
0.0084 |
| 214 |
PANNICULITIS |
20 |
0.0083 |
| 215 |
FINGER DEFORMITY |
40 |
0.0082 |
| 216 |
INJECTION SITE PRURITUS |
553 |
0.0082 |
| 217 |
BLOOD PARATHYROID HORMONE DECREASED |
12 |
0.0081 |
| 218 |
MUCORMYCOSIS |
21 |
0.0081 |
| 219 |
INJECTION SITE REACTION |
555 |
0.0081 |
| 220 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
205 |
0.0080 |
| 221 |
ILL-DEFINED DISORDER |
475 |
0.0078 |
| 222 |
IMPAIRED QUALITY OF LIFE |
112 |
0.0078 |
| 223 |
PYODERMA GANGRENOSUM |
28 |
0.0078 |
| 224 |
ASPERGILLUS INFECTION |
51 |
0.0078 |
| 225 |
GESTATIONAL HYPERTENSION |
10 |
0.0077 |
| 226 |
HEPATITIS |
198 |
0.0077 |
| 227 |
ENTEROBACTER INFECTION |
13 |
0.0077 |
| 228 |
INJECTION SITE SCAR |
22 |
0.0077 |
| 229 |
LIVER ABSCESS |
25 |
0.0077 |
| 230 |
BLOOD PRESSURE SYSTOLIC ABNORMAL |
19 |
0.0077 |
| 231 |
QUALITY OF LIFE DECREASED |
103 |
0.0077 |
| 232 |
ORAL FUNGAL INFECTION |
21 |
0.0077 |
| 233 |
HYPERTRANSAMINASAEMIA |
53 |
0.0076 |
| 234 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
10 |
0.0076 |
| 235 |
STENT PLACEMENT |
61 |
0.0076 |
| 236 |
KNEE ARTHROPLASTY |
159 |
0.0075 |
| 237 |
BRONCHIAL HYPERREACTIVITY |
9 |
0.0075 |
| 238 |
IMMUNE THROMBOCYTOPENIA |
34 |
0.0074 |
| 239 |
HEPATOTOXICITY |
163 |
0.0073 |
| 240 |
DIFFUSE LARGE B-CELL LYMPHOMA |
56 |
0.0073 |
| 241 |
VITILIGO |
17 |
0.0072 |
| 242 |
PNEUMONIA PSEUDOMONAL |
11 |
0.0072 |
| 243 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
201 |
0.0071 |
| 244 |
PHOTOSENSITIVITY REACTION |
117 |
0.0071 |
| 245 |
TENDERNESS |
73 |
0.0070 |
| 246 |
BRONCHOPULMONARY ASPERGILLOSIS |
54 |
0.0070 |
| 247 |
RETINITIS |
12 |
0.0069 |
| 248 |
SACROILIITIS |
13 |
0.0069 |
| 249 |
RESPIRATORY ACIDOSIS |
27 |
0.0069 |
| 250 |
EXFOLIATIVE RASH |
18 |
0.0068 |
| 251 |
BK VIRUS INFECTION |
23 |
0.0068 |
| 252 |
INTERSTITIAL LUNG DISEASE |
328 |
0.0068 |
| 253 |
FACET JOINT SYNDROME |
22 |
0.0068 |
| 254 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
14 |
0.0068 |
| 255 |
PURPURA |
59 |
0.0067 |
| 256 |
EPICONDYLITIS |
10 |
0.0066 |
| 257 |
SWOLLEN JOINT COUNT INCREASED |
21 |
0.0066 |
| 258 |
ERYSIPELAS |
33 |
0.0066 |
| 259 |
LUNG OPACITY |
17 |
0.0064 |
| 260 |
PULMONARY FUNCTION TEST ABNORMAL |
10 |
0.0064 |
| 261 |
INFECTION |
921 |
0.0064 |
| 262 |
LIVER FUNCTION TEST INCREASED |
136 |
0.0063 |
| 263 |
EXTREMITY NECROSIS |
11 |
0.0063 |
| 264 |
STREPTOCOCCAL INFECTION |
35 |
0.0063 |
| 265 |
SCLERITIS |
10 |
0.0062 |
| 266 |
BONE EROSION |
22 |
0.0062 |
| 267 |
HISTOPLASMOSIS |
11 |
0.0062 |
| 268 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
340 |
0.0062 |
| 269 |
INJECTION SITE WARMTH |
127 |
0.0062 |
| 270 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
436 |
0.0061 |
| 271 |
VASOPLEGIA SYNDROME |
10 |
0.0061 |
| 272 |
AUTOIMMUNE THYROIDITIS |
23 |
0.0061 |
| 273 |
INJECTION SITE DISCOLOURATION |
76 |
0.0061 |
| 274 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
58 |
0.0061 |
| 275 |
DRUG USE DISORDER |
51 |
0.0061 |
| 276 |
SYNOVIAL CYST |
28 |
0.0061 |
| 277 |
OFF LABEL USE |
5297 |
0.0060 |
| 278 |
THROMBOCYTOSIS |
22 |
0.0060 |
| 279 |
SALMONELLOSIS |
10 |
0.0059 |
| 280 |
INJECTION SITE ERYTHEMA |
732 |
0.0059 |
| 281 |
ESCHERICHIA SEPSIS |
17 |
0.0059 |
| 282 |
TYPE IV HYPERSENSITIVITY REACTION |
16 |
0.0058 |
| 283 |
CHOLESTATIC LIVER INJURY |
13 |
0.0058 |
| 284 |
INJECTION SITE OEDEMA |
10 |
0.0058 |
| 285 |
STAPHYLOCOCCAL BACTERAEMIA |
25 |
0.0057 |
| 286 |
DERMATITIS EXFOLIATIVE GENERALISED |
20 |
0.0057 |
| 287 |
OSTEOPOROTIC FRACTURE |
11 |
0.0057 |
| 288 |
CONDITION AGGRAVATED |
1743 |
0.0057 |
| 289 |
DEEP VEIN THROMBOSIS |
371 |
0.0057 |
| 290 |
FUNGAL SKIN INFECTION |
23 |
0.0057 |
| 291 |
PNEUMONIA CYTOMEGALOVIRAL |
11 |
0.0057 |
| 292 |
OSTEOMYELITIS |
102 |
0.0056 |
| 293 |
BACTERAEMIA |
66 |
0.0056 |
| 294 |
DISSEMINATED TUBERCULOSIS |
14 |
0.0055 |
| 295 |
HYPOKALAEMIA |
251 |
0.0054 |
| 296 |
INTENTIONAL PRODUCT USE ISSUE |
474 |
0.0054 |
| 297 |
PERIPHERAL VENOUS DISEASE |
22 |
0.0054 |
| 298 |
LIMB DISCOMFORT |
164 |
0.0053 |
| 299 |
SPLENOMEGALY |
62 |
0.0053 |
| 300 |
VENOOCCLUSIVE DISEASE |
13 |
0.0052 |
| 301 |
INFLAMMATION |
268 |
0.0052 |
| 302 |
ESCHERICHIA BACTERAEMIA |
12 |
0.0051 |
| 303 |
INJECTION SITE INDURATION |
66 |
0.0051 |
| 304 |
SPINAL COLUMN STENOSIS |
24 |
0.0051 |
| 305 |
PRESCRIBED UNDERDOSE |
101 |
0.0051 |
| 306 |
SWELLING |
469 |
0.0050 |
| 307 |
VENTRICULAR DYSFUNCTION |
13 |
0.0050 |
| 308 |
ONYCHOMADESIS |
21 |
0.0050 |
| 309 |
GLOSSODYNIA |
112 |
0.0050 |
| 310 |
ARTHRITIS INFECTIVE |
23 |
0.0050 |
| 311 |
EMBOLISM |
41 |
0.0049 |
| 312 |
ORAL HERPES |
95 |
0.0049 |
| 313 |
AUTOIMMUNE DISORDER |
47 |
0.0048 |
| 314 |
INJECTION SITE IRRITATION |
61 |
0.0048 |
| 315 |
FIBRIN D DIMER INCREASED |
17 |
0.0048 |
| 316 |
HYPOGAMMAGLOBULINAEMIA |
31 |
0.0047 |
| 317 |
CYSTITIS HAEMORRHAGIC |
19 |
0.0047 |
| 318 |
INFUSION SITE REACTION |
14 |
0.0047 |
| 319 |
HYPERLIPIDAEMIA |
56 |
0.0047 |
| 320 |
VENOOCCLUSIVE LIVER DISEASE |
23 |
0.0047 |
| 321 |
LOCALISED INFECTION |
112 |
0.0046 |
| 322 |
PLEURAL EFFUSION |
280 |
0.0046 |
| 323 |
INJECTION SITE SWELLING |
352 |
0.0046 |
| 324 |
JOINT INJURY |
98 |
0.0046 |
| 325 |
PULMONARY EMBOLISM |
435 |
0.0046 |
| 326 |
ENCEPHALITIS |
31 |
0.0045 |
| 327 |
HEPATIC CYTOLYSIS |
57 |
0.0045 |
| 328 |
BLOOD CHOLESTEROL INCREASED |
208 |
0.0045 |
| 329 |
INJECTION SITE VESICLES |
27 |
0.0045 |
| 330 |
IMPAIRED HEALING |
145 |
0.0044 |
| 331 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
44 |
0.0044 |
| 332 |
PUSTULAR PSORIASIS |
15 |
0.0044 |
| 333 |
LOSS OF CONSCIOUSNESS |
559 |
0.0044 |
| 334 |
CERVICAL VERTEBRAL FRACTURE |
15 |
0.0043 |
| 335 |
ENTEROCOCCAL INFECTION |
21 |
0.0043 |
| 336 |
CLOSTRIDIUM DIFFICILE COLITIS |
46 |
0.0043 |
| 337 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
11 |
0.0043 |
| 338 |
LEUKOPENIA |
216 |
0.0043 |
| 339 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
153 |
0.0043 |
| 340 |
HERPES SIMPLEX |
28 |
0.0043 |
| 341 |
DUODENAL ULCER PERFORATION |
32 |
0.0043 |
| 342 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
76 |
0.0043 |
| 343 |
HIDRADENITIS |
39 |
0.0043 |
| 344 |
STAPHYLOCOCCAL SEPSIS |
21 |
0.0042 |
| 345 |
NORMAL NEWBORN |
23 |
0.0042 |
| 346 |
PNEUMATOSIS INTESTINALIS |
12 |
0.0042 |
| 347 |
IMMUNOSUPPRESSION |
37 |
0.0042 |
| 348 |
SEPSIS |
466 |
0.0042 |
| 349 |
MUSCULOSKELETAL PAIN |
217 |
0.0041 |
| 350 |
HYPERURICAEMIA |
17 |
0.0041 |
| 351 |
VIRAL INFECTION |
137 |
0.0041 |
| 352 |
WOUND INFECTION |
45 |
0.0041 |
| 353 |
PSORIASIS |
535 |
0.0041 |
| 354 |
REBOUND EFFECT |
46 |
0.0041 |
| 355 |
PNEUMONIA FUNGAL |
16 |
0.0041 |
| 356 |
LIVER INJURY |
99 |
0.0040 |
| 357 |
CARDIAC DYSFUNCTION |
15 |
0.0040 |
| 358 |
INJECTION SITE BRUISING |
321 |
0.0040 |
| 359 |
STEM CELL TRANSPLANT |
10 |
0.0040 |
| 360 |
SUSPECTED OFF LABEL USE |
18 |
0.0040 |
| 361 |
CANDIDA INFECTION |
67 |
0.0040 |
| 362 |
KLEBSIELLA INFECTION |
20 |
0.0040 |
| 363 |
POOR QUALITY SLEEP |
85 |
0.0039 |
| 364 |
HAEMODYNAMIC INSTABILITY |
30 |
0.0039 |
| 365 |
GUILLAIN-BARRE SYNDROME |
19 |
0.0039 |
| 366 |
IMMUNE SYSTEM DISORDER |
51 |
0.0039 |
| 367 |
SPONDYLITIS |
14 |
0.0038 |
| 368 |
GASTROINTESTINAL PERFORATION |
16 |
0.0038 |
| 369 |
SYMPTOM RECURRENCE |
23 |
0.0038 |
| 370 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
19 |
0.0038 |
| 371 |
PERICARDIAL EFFUSION |
88 |
0.0038 |
| 372 |
CARDIAC TAMPONADE |
18 |
0.0038 |
| 373 |
INJECTION SITE MASS |
140 |
0.0038 |
| 374 |
CORONAVIRUS INFECTION |
25 |
0.0038 |
| 375 |
ARTHROPOD BITE |
28 |
0.0038 |
| 376 |
PSEUDOMONAS INFECTION |
32 |
0.0037 |
| 377 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
10 |
0.0037 |
| 378 |
INTENTIONAL PRODUCT MISUSE |
326 |
0.0037 |
| 379 |
MOUTH ULCERATION |
78 |
0.0037 |
| 380 |
HYPERCAPNIA |
11 |
0.0036 |
| 381 |
OSTEOARTHRITIS |
154 |
0.0036 |
| 382 |
OTITIS MEDIA |
12 |
0.0036 |
| 383 |
STOMATITIS |
219 |
0.0036 |
| 384 |
RENAL FAILURE |
477 |
0.0036 |
| 385 |
THROMBOTIC MICROANGIOPATHY |
35 |
0.0036 |
| 386 |
MYOPATHY |
31 |
0.0036 |
| 387 |
SKIN DISORDER |
119 |
0.0036 |
| 388 |
BRAIN DEATH |
11 |
0.0036 |
| 389 |
CELLULITIS |
179 |
0.0035 |
| 390 |
BURSITIS |
43 |
0.0035 |
| 391 |
LYMPHADENOPATHY |
125 |
0.0035 |
| 392 |
VASCULITIS |
41 |
0.0035 |
| 393 |
BACK DISORDER |
57 |
0.0035 |
| 394 |
PYREXIA |
1189 |
0.0034 |
| 395 |
IMMOBILE |
15 |
0.0034 |
| 396 |
INJECTION SITE PAIN |
1047 |
0.0034 |
| 397 |
HEPATIC STEATOSIS |
63 |
0.0034 |
| 398 |
THORACIC VERTEBRAL FRACTURE |
10 |
0.0034 |
| 399 |
IMPAIRED WORK ABILITY |
72 |
0.0034 |
| 400 |
NECK PAIN |
188 |
0.0034 |
| 401 |
INJECTION SITE INFECTION |
11 |
0.0033 |
| 402 |
BREAST SWELLING |
9 |
0.0033 |
| 403 |
LIVE BIRTH |
28 |
0.0033 |
| 404 |
MIXED LIVER INJURY |
10 |
0.0033 |
| 405 |
COVID-19 |
583 |
0.0033 |
| 406 |
DRUG INEFFECTIVE |
4356 |
0.0033 |
| 407 |
OLIGOHYDRAMNIOS |
11 |
0.0033 |
| 408 |
ESCHERICHIA URINARY TRACT INFECTION |
14 |
0.0033 |
| 409 |
ENTERITIS |
21 |
0.0033 |
| 410 |
OESOPHAGEAL CANDIDIASIS |
13 |
0.0033 |
| 411 |
TONSILLITIS |
17 |
0.0033 |
| 412 |
HYPERTRIGLYCERIDAEMIA |
19 |
0.0032 |
| 413 |
LUNG DISORDER |
159 |
0.0032 |
| 414 |
IMPAIRED GASTRIC EMPTYING |
44 |
0.0032 |
| 415 |
FEAR OF INJECTION |
23 |
0.0032 |
| 416 |
THERAPY PARTIAL RESPONDER |
50 |
0.0032 |
| 417 |
PRESCRIBED OVERDOSE |
62 |
0.0032 |
| 418 |
TOOTHACHE |
58 |
0.0032 |
| 419 |
PRODUCT DOSE OMISSION ISSUE |
940 |
0.0032 |
| 420 |
ONYCHOMYCOSIS |
14 |
0.0032 |
| 421 |
BLEPHAROSPASM |
20 |
0.0032 |
| 422 |
ARTHRITIS BACTERIAL |
13 |
0.0032 |
| 423 |
ADVERSE REACTION |
42 |
0.0032 |
| 424 |
THROMBOSIS |
254 |
0.0032 |
| 425 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
50 |
0.0032 |
| 426 |
ULCER |
50 |
0.0031 |
| 427 |
SCIATICA |
50 |
0.0031 |
| 428 |
CYTOMEGALOVIRUS INFECTION |
52 |
0.0031 |
| 429 |
DISSEMINATED INTRAVASCULAR COAGULATION |
44 |
0.0031 |
| 430 |
EMBOLIC STROKE |
11 |
0.0031 |
| 431 |
MENINGITIS ASEPTIC |
14 |
0.0031 |
| 432 |
MUSCULOSKELETAL STIFFNESS |
271 |
0.0031 |
| 433 |
FAILURE TO THRIVE |
16 |
0.0031 |
| 434 |
ORAL PAIN |
69 |
0.0031 |
| 435 |
COELIAC DISEASE |
30 |
0.0031 |
| 436 |
SPINAL FRACTURE |
61 |
0.0030 |
| 437 |
LYMPHOPENIA |
43 |
0.0030 |
| 438 |
HELICOBACTER INFECTION |
31 |
0.0030 |
| 439 |
BASAL CELL CARCINOMA |
47 |
0.0030 |
| 440 |
CYTOLYTIC HEPATITIS |
10 |
0.0030 |
| 441 |
HYPERNATRAEMIA |
15 |
0.0030 |
| 442 |
TIBIA FRACTURE |
14 |
0.0030 |
| 443 |
OEDEMA |
161 |
0.0030 |
| 444 |
SKIN FISSURES |
58 |
0.0030 |
| 445 |
HEPATOCELLULAR INJURY |
42 |
0.0030 |
| 446 |
PHARYNGITIS STREPTOCOCCAL |
32 |
0.0030 |
| 447 |
GRIP STRENGTH DECREASED |
26 |
0.0030 |
| 448 |
GESTATIONAL DIABETES |
14 |
0.0029 |
| 449 |
BREAST CANCER STAGE III |
19 |
0.0029 |
| 450 |
PROTEIN TOTAL DECREASED |
11 |
0.0029 |
| 451 |
ARTHRALGIA |
1208 |
0.0029 |
| 452 |
MYOSITIS |
26 |
0.0029 |
| 453 |
MUSCLE INJURY |
24 |
0.0029 |
| 454 |
MYOCARDITIS |
33 |
0.0029 |
| 455 |
AUTOIMMUNE HEPATITIS |
20 |
0.0029 |
| 456 |
EOSINOPHILIA |
50 |
0.0029 |
| 457 |
INJECTION SITE DISCOMFORT |
30 |
0.0028 |
| 458 |
URTICARIA |
477 |
0.0028 |
| 459 |
EAR INFECTION |
75 |
0.0028 |
| 460 |
UROSEPSIS |
26 |
0.0028 |
| 461 |
ANKYLOSING SPONDYLITIS |
37 |
0.0028 |
| 462 |
GAIT INABILITY |
93 |
0.0028 |
| 463 |
INTESTINAL PERFORATION |
31 |
0.0028 |
| 464 |
JOINT RANGE OF MOTION DECREASED |
37 |
0.0028 |
| 465 |
LUPUS-LIKE SYNDROME |
25 |
0.0028 |
| 466 |
SARCOIDOSIS |
13 |
0.0027 |
| 467 |
INJECTION SITE NODULE |
30 |
0.0027 |
| 468 |
WOUND |
76 |
0.0027 |
| 469 |
PERIPHERAL SWELLING |
418 |
0.0027 |
| 470 |
SPINAL FUSION SURGERY |
11 |
0.0027 |
| 471 |
SKIN NECROSIS |
14 |
0.0027 |
| 472 |
SKIN MASS |
18 |
0.0027 |
| 473 |
ABSCESS |
43 |
0.0027 |
| 474 |
INTRACRANIAL PRESSURE INCREASED |
15 |
0.0027 |
| 475 |
BONE DENSITY ABNORMAL |
10 |
0.0027 |
| 476 |
SKIN INFECTION |
30 |
0.0027 |
| 477 |
STATUS EPILEPTICUS |
30 |
0.0027 |
| 478 |
TOOTH DISORDER |
59 |
0.0027 |
| 479 |
VASCULAR DEVICE INFECTION |
12 |
0.0026 |
| 480 |
PULMONARY HYPERTENSION |
55 |
0.0026 |
| 481 |
THERAPEUTIC RESPONSE DECREASED |
160 |
0.0026 |
| 482 |
NYSTAGMUS |
14 |
0.0026 |
| 483 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
45 |
0.0026 |
| 484 |
PAIN |
1603 |
0.0026 |
| 485 |
PRODUCT USE ISSUE |
490 |
0.0026 |
| 486 |
BLOOD PRESSURE FLUCTUATION |
62 |
0.0026 |
| 487 |
CYST |
32 |
0.0026 |
| 488 |
VIRAL LOAD INCREASED |
10 |
0.0026 |
| 489 |
PULMONARY TUBERCULOSIS |
11 |
0.0026 |
| 490 |
UMBILICAL HERNIA |
12 |
0.0026 |
| 491 |
DIARRHOEA HAEMORRHAGIC |
24 |
0.0026 |
| 492 |
CARDIOPULMONARY FAILURE |
10 |
0.0026 |
| 493 |
GOUT |
46 |
0.0026 |
| 494 |
ORAL INFECTION |
10 |
0.0026 |
| 495 |
SKIN REACTION |
36 |
0.0026 |
| 496 |
HEPATIC ENZYME INCREASED |
174 |
0.0025 |
| 497 |
RENAL TUBULAR NECROSIS |
25 |
0.0025 |
| 498 |
LEUKOCYTOSIS |
46 |
0.0025 |
| 499 |
INTENTIONAL DOSE OMISSION |
72 |
0.0025 |
| 500 |
CONTUSION |
243 |
0.0025 |
| 501 |
HYPERSENSITIVITY |
465 |
0.0025 |
| 502 |
HYPERCHOLESTEROLAEMIA |
24 |
0.0025 |
| 503 |
ENCEPHALOPATHY |
60 |
0.0024 |
| 504 |
AGRANULOCYTOSIS |
45 |
0.0024 |
| 505 |
PHARYNGITIS |
30 |
0.0024 |
| 506 |
TRANSAMINASES INCREASED |
53 |
0.0024 |
| 507 |
INTERVERTEBRAL DISC DEGENERATION |
22 |
0.0024 |
| 508 |
OSTEOPENIA |
36 |
0.0024 |
| 509 |
JOINT DISLOCATION |
25 |
0.0024 |
| 510 |
SUBARACHNOID HAEMORRHAGE |
24 |
0.0024 |
| 511 |
SYRINGE ISSUE |
41 |
0.0023 |
| 512 |
RESPIRATORY FAILURE |
170 |
0.0023 |
| 513 |
JOINT STIFFNESS |
61 |
0.0023 |
| 514 |
HEPATITIS B |
14 |
0.0023 |
| 515 |
PROTEINURIA |
44 |
0.0023 |
| 516 |
ESCHERICHIA INFECTION |
19 |
0.0023 |
| 517 |
PSYCHIATRIC SYMPTOM |
17 |
0.0023 |
| 518 |
FOETAL GROWTH RESTRICTION |
14 |
0.0023 |
| 519 |
PNEUMONIA BACTERIAL |
21 |
0.0023 |
| 520 |
UVEITIS |
31 |
0.0023 |
| 521 |
RASH |
996 |
0.0023 |
| 522 |
INFLAMMATORY BOWEL DISEASE |
22 |
0.0022 |
| 523 |
PSORIATIC ARTHROPATHY |
91 |
0.0022 |
| 524 |
OSTEOPOROSIS |
92 |
0.0022 |
| 525 |
RASH MACULAR |
78 |
0.0022 |
| 526 |
PRODUCT LABEL CONFUSION |
13 |
0.0022 |
| 527 |
GRAFT VERSUS HOST DISEASE |
16 |
0.0022 |
| 528 |
PANCYTOPENIA |
124 |
0.0022 |
| 529 |
HAEMOLYSIS |
17 |
0.0022 |
| 530 |
CATARACT |
131 |
0.0022 |
| 531 |
FOLLICULITIS |
23 |
0.0022 |
| 532 |
UPPER-AIRWAY COUGH SYNDROME |
18 |
0.0022 |
| 533 |
ACUTE GRAFT VERSUS HOST DISEASE |
10 |
0.0022 |
| 534 |
SPINAL COMPRESSION FRACTURE |
18 |
0.0022 |
| 535 |
NAIL DISORDER |
19 |
0.0022 |
| 536 |
BONE MARROW FAILURE |
44 |
0.0022 |
| 537 |
COAGULOPATHY |
36 |
0.0022 |
| 538 |
TUMOUR LYSIS SYNDROME |
19 |
0.0022 |
| 539 |
SINUSITIS |
220 |
0.0021 |
| 540 |
KIDNEY INFECTION |
42 |
0.0021 |
| 541 |
HEART RATE DECREASED |
75 |
0.0021 |
| 542 |
DRUG-INDUCED LIVER INJURY |
67 |
0.0021 |
| 543 |
WALKING AID USER |
14 |
0.0021 |
| 544 |
MATERNAL EXPOSURE DURING PREGNANCY |
189 |
0.0021 |
| 545 |
ILLNESS |
218 |
0.0021 |
| 546 |
NIGHT SWEATS |
68 |
0.0021 |
| 547 |
PRODUCT USE IN UNAPPROVED INDICATION |
523 |
0.0021 |
| 548 |
VITAMIN D DECREASED |
18 |
0.0021 |
| 549 |
RASH PRURITIC |
114 |
0.0021 |
| 550 |
LEFT VENTRICULAR DYSFUNCTION |
14 |
0.0021 |
| 551 |
PYELONEPHRITIS |
18 |
0.0021 |
| 552 |
LIQUID PRODUCT PHYSICAL ISSUE |
15 |
0.0021 |
| 553 |
ORAL CANDIDIASIS |
27 |
0.0020 |
| 554 |
ADVERSE DRUG REACTION |
184 |
0.0020 |
| 555 |
LABORATORY TEST ABNORMAL |
60 |
0.0020 |
| 556 |
COVID-19 PNEUMONIA |
24 |
0.0020 |
| 557 |
NEEDLE ISSUE |
59 |
0.0020 |
| 558 |
HIP ARTHROPLASTY |
31 |
0.0020 |
| 559 |
HEPATIC ENZYME ABNORMAL |
10 |
0.0020 |
| 560 |
INFUSION RELATED REACTION |
132 |
0.0020 |
| 561 |
PRODUCT DOSE OMISSION IN ERROR |
56 |
0.0020 |
| 562 |
EXOSTOSIS |
18 |
0.0020 |
| 563 |
RASH ERYTHEMATOUS |
94 |
0.0020 |
| 564 |
ANGIOPATHY |
11 |
0.0020 |
| 565 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
17 |
0.0020 |
| 566 |
FUNGAL INFECTION |
65 |
0.0019 |
| 567 |
INFLUENZA |
217 |
0.0019 |
| 568 |
PRODUCT DISTRIBUTION ISSUE |
18 |
0.0019 |
| 569 |
HYPERTENSION |
411 |
0.0019 |
| 570 |
UPPER RESPIRATORY TRACT INFECTION |
89 |
0.0019 |
| 571 |
EOSINOPHIL COUNT INCREASED |
16 |
0.0019 |
| 572 |
RESPIRATORY TRACT INFECTION |
50 |
0.0019 |
| 573 |
GASTROENTERITIS |
28 |
0.0019 |
| 574 |
HERPES VIRUS INFECTION |
11 |
0.0019 |
| 575 |
GASTROINTESTINAL INFECTION |
17 |
0.0019 |
| 576 |
SKIN WARM |
11 |
0.0019 |
| 577 |
VOMITING |
885 |
0.0019 |
| 578 |
HYPERCALCAEMIA |
23 |
0.0019 |
| 579 |
MASS |
26 |
0.0019 |
| 580 |
PRODUCT DOSE OMISSION |
121 |
0.0019 |
| 581 |
HYSTERECTOMY |
16 |
0.0018 |
| 582 |
HEPATITIS ACUTE |
12 |
0.0018 |
| 583 |
BACK INJURY |
20 |
0.0018 |
| 584 |
STAPHYLOCOCCAL INFECTION |
60 |
0.0018 |
| 585 |
SARS-COV-2 TEST POSITIVE |
24 |
0.0018 |
| 586 |
UNDERDOSE |
132 |
0.0018 |
| 587 |
DRUG RESISTANCE |
46 |
0.0018 |
| 588 |
BRONCHIECTASIS |
12 |
0.0018 |
| 589 |
FURUNCLE |
14 |
0.0018 |
| 590 |
ASPARTATE AMINOTRANSFERASE INCREASED |
93 |
0.0017 |
| 591 |
PHARYNGEAL SWELLING |
17 |
0.0017 |
| 592 |
MOUTH SWELLING |
10 |
0.0017 |
| 593 |
HEPATOMEGALY |
17 |
0.0017 |
| 594 |
PULMONARY ARTERIAL HYPERTENSION |
25 |
0.0017 |
| 595 |
CONJUNCTIVITIS |
32 |
0.0017 |
| 596 |
HYPOTENSION |
346 |
0.0017 |
| 597 |
ACUTE RESPIRATORY FAILURE |
33 |
0.0017 |
| 598 |
ALANINE AMINOTRANSFERASE INCREASED |
105 |
0.0017 |
| 599 |
HYPOXIA |
60 |
0.0017 |
| 600 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
11 |
0.0017 |
| 601 |
ANORECTAL DISCOMFORT |
9 |
0.0017 |
| 602 |
SPINAL DISORDER |
16 |
0.0017 |
| 603 |
ABDOMINAL DISCOMFORT |
282 |
0.0017 |
| 604 |
EXPOSURE DURING PREGNANCY |
104 |
0.0017 |
| 605 |
DERMATITIS |
35 |
0.0017 |
| 606 |
TYPE 2 DIABETES MELLITUS |
56 |
0.0017 |
| 607 |
NASOPHARYNGITIS |
305 |
0.0017 |
| 608 |
MENINGITIS |
11 |
0.0016 |
| 609 |
PNEUMOTHORAX |
26 |
0.0016 |
| 610 |
ULCER HAEMORRHAGE |
11 |
0.0016 |
| 611 |
EMOTIONAL DISORDER |
50 |
0.0016 |
| 612 |
SPINAL PAIN |
19 |
0.0016 |
| 613 |
DISABILITY |
32 |
0.0016 |
| 614 |
TACHYPNOEA |
22 |
0.0016 |
| 615 |
BACTERIAL INFECTION |
30 |
0.0016 |
| 616 |
RESPIRATORY DISORDER |
48 |
0.0016 |
| 617 |
PREGNANCY |
32 |
0.0016 |
| 618 |
EYE INFECTION |
18 |
0.0016 |
| 619 |
RENAL IMPAIRMENT |
133 |
0.0016 |
| 620 |
THROMBOCYTOPENIA |
176 |
0.0016 |
| 621 |
MALAISE |
690 |
0.0016 |
| 622 |
BLOOD URIC ACID INCREASED |
9 |
0.0016 |
| 623 |
HAEMOGLOBIN DECREASED |
160 |
0.0016 |
| 624 |
FOOD ALLERGY |
12 |
0.0016 |
| 625 |
ATELECTASIS |
15 |
0.0016 |
| 626 |
DISEASE PROGRESSION |
183 |
0.0015 |
| 627 |
EAR PAIN |
30 |
0.0015 |
| 628 |
LIP DRY |
14 |
0.0015 |
| 629 |
NEUROTOXICITY |
27 |
0.0015 |
| 630 |
GASTROINTESTINAL DISORDER |
138 |
0.0015 |
| 631 |
IRRITABLE BOWEL SYNDROME |
33 |
0.0015 |
| 632 |
ANAPHYLACTIC REACTION |
85 |
0.0015 |
| 633 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
45 |
0.0015 |
| 634 |
PULMONARY HAEMORRHAGE |
12 |
0.0015 |
| 635 |
URINARY TRACT INFECTION |
260 |
0.0015 |
| 636 |
SCRATCH |
16 |
0.0015 |
| 637 |
INJECTION SITE HAEMATOMA |
22 |
0.0015 |
| 638 |
ACUTE KIDNEY INJURY |
230 |
0.0015 |
| 639 |
ANAEMIA |
286 |
0.0015 |
| 640 |
BLOOD DISORDER |
12 |
0.0015 |
| 641 |
OROPHARYNGEAL PAIN |
138 |
0.0015 |
| 642 |
POSTOPERATIVE WOUND INFECTION |
10 |
0.0015 |
| 643 |
WEIGHT INCREASED |
331 |
0.0015 |
| 644 |
SKIN ULCER |
38 |
0.0015 |
| 645 |
DRUG ERUPTION |
26 |
0.0015 |
| 646 |
BLISTER |
82 |
0.0015 |
| 647 |
POOR VENOUS ACCESS |
15 |
0.0014 |
| 648 |
PREMATURE DELIVERY |
23 |
0.0014 |
| 649 |
PETECHIAE |
15 |
0.0014 |
| 650 |
ABDOMINAL PAIN |
334 |
0.0014 |
| 651 |
WHITE BLOOD CELL COUNT INCREASED |
55 |
0.0014 |
| 652 |
PNEUMONITIS |
39 |
0.0014 |
| 653 |
SLEEP DISORDER |
101 |
0.0014 |
| 654 |
BLOOD TEST ABNORMAL |
20 |
0.0014 |
| 655 |
RESPIRATORY DISTRESS |
39 |
0.0014 |
| 656 |
CHOLESTASIS |
27 |
0.0014 |
| 657 |
PNEUMONIA |
455 |
0.0014 |
| 658 |
DRUG EFFECT INCOMPLETE |
51 |
0.0014 |
| 659 |
ELECTROCARDIOGRAM ABNORMAL |
11 |
0.0014 |
| 660 |
SKIN LESION |
38 |
0.0014 |
| 661 |
PRODUCT PRESCRIBING ISSUE |
30 |
0.0014 |
| 662 |
BODY TEMPERATURE INCREASED |
28 |
0.0014 |
| 663 |
FRUSTRATION TOLERANCE DECREASED |
11 |
0.0014 |
| 664 |
LYMPHOMA |
21 |
0.0014 |
| 665 |
DIARRHOEA |
875 |
0.0014 |
| 666 |
DRUG EFFECT LESS THAN EXPECTED |
20 |
0.0013 |
| 667 |
SHOCK |
31 |
0.0013 |
| 668 |
FACIAL PAIN |
12 |
0.0013 |
| 669 |
NEPHROPATHY TOXIC |
15 |
0.0013 |
| 670 |
PRODUCT USE COMPLAINT |
21 |
0.0013 |
| 671 |
SYNCOPE |
132 |
0.0013 |
| 672 |
DRUG EFFECT DECREASED |
71 |
0.0013 |
| 673 |
MEDICATION ERROR |
73 |
0.0013 |
| 674 |
HAEMODIALYSIS |
11 |
0.0013 |
| 675 |
OSTEONECROSIS |
43 |
0.0013 |
| 676 |
HEPATIC FAILURE |
39 |
0.0013 |
| 677 |
COLITIS |
49 |
0.0013 |
| 678 |
MIGRAINE |
122 |
0.0013 |
| 679 |
HEPATIC CIRRHOSIS |
24 |
0.0013 |
| 680 |
ABORTION INDUCED |
12 |
0.0013 |
| 681 |
RASH GENERALISED |
33 |
0.0013 |
| 682 |
GASTROINTESTINAL PAIN |
14 |
0.0013 |
| 683 |
SKIN DISCOLOURATION |
58 |
0.0013 |
| 684 |
BURNING SENSATION |
88 |
0.0013 |
| 685 |
LOWER RESPIRATORY TRACT INFECTION |
57 |
0.0013 |
| 686 |
TRANSPLANT REJECTION |
10 |
0.0012 |
| 687 |
DIABETES MELLITUS |
95 |
0.0012 |
| 688 |
RESPIRATORY RATE INCREASED |
11 |
0.0012 |
| 689 |
ALOPECIA |
243 |
0.0012 |
| 690 |
POST PROCEDURAL INFECTION |
10 |
0.0012 |
| 691 |
TACHYCARDIA |
109 |
0.0012 |
| 692 |
BEDRIDDEN |
16 |
0.0012 |
| 693 |
NAUSEA |
961 |
0.0012 |
| 694 |
ERYTHEMA |
248 |
0.0012 |
| 695 |
NEUTROPENIA |
163 |
0.0012 |
| 696 |
ABDOMINAL PAIN UPPER |
246 |
0.0012 |
| 697 |
GLAUCOMA |
23 |
0.0012 |
| 698 |
FEAR |
32 |
0.0012 |
| 699 |
BLOOD IRON DECREASED |
14 |
0.0012 |
| 700 |
LIMB INJURY |
32 |
0.0012 |
| 701 |
ANGIOEDEMA |
52 |
0.0012 |
| 702 |
WHITE BLOOD CELL COUNT DECREASED |
127 |
0.0012 |
| 703 |
DEVICE RELATED INFECTION |
18 |
0.0012 |
| 704 |
RASH MACULO-PAPULAR |
26 |
0.0012 |
| 705 |
BLOOD PRESSURE INCREASED |
178 |
0.0012 |
| 706 |
HIATUS HERNIA |
15 |
0.0012 |
| 707 |
PLATELET COUNT INCREASED |
15 |
0.0011 |
| 708 |
BLOOD ALBUMIN DECREASED |
9 |
0.0011 |
| 709 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
25 |
0.0011 |
| 710 |
MUSCULAR WEAKNESS |
128 |
0.0011 |
| 711 |
PRURITUS |
431 |
0.0011 |
| 712 |
ADVERSE EVENT |
103 |
0.0011 |
| 713 |
BODY TEMPERATURE DECREASED |
11 |
0.0011 |
| 714 |
RASH PAPULAR |
25 |
0.0011 |
| 715 |
LIGAMENT SPRAIN |
11 |
0.0011 |
| 716 |
EPILEPSY |
34 |
0.0011 |
| 717 |
ANAL INCONTINENCE |
10 |
0.0011 |
| 718 |
INSURANCE ISSUE |
17 |
0.0011 |
| 719 |
PARAESTHESIA ORAL |
16 |
0.0011 |
| 720 |
LIVER DISORDER |
49 |
0.0011 |
| 721 |
MYOCARDIAL INFARCTION |
192 |
0.0011 |
| 722 |
ACUTE HEPATIC FAILURE |
15 |
0.0011 |
| 723 |
DISEASE RECURRENCE |
52 |
0.0011 |
| 724 |
LOWER LIMB FRACTURE |
21 |
0.0011 |
| 725 |
VENTRICULAR TACHYCARDIA |
18 |
0.0011 |
| 726 |
NERVOUS SYSTEM DISORDER |
34 |
0.0011 |
| 727 |
JAUNDICE |
29 |
0.0011 |
| 728 |
HYPOMAGNESAEMIA |
15 |
0.0011 |
| 729 |
BLOOD TRIGLYCERIDES INCREASED |
19 |
0.0011 |
| 730 |
NEUTROPHIL COUNT INCREASED |
11 |
0.0011 |
| 731 |
INFLUENZA LIKE ILLNESS |
88 |
0.0011 |
| 732 |
CHEST PAIN |
198 |
0.0011 |
| 733 |
NEPHROLITHIASIS |
49 |
0.0011 |
| 734 |
BRONCHITIS |
79 |
0.0011 |
| 735 |
PREMATURE BABY |
32 |
0.0011 |
| 736 |
MITRAL VALVE INCOMPETENCE |
12 |
0.0011 |
| 737 |
PAIN IN JAW |
30 |
0.0011 |
| 738 |
INSOMNIA |
282 |
0.0011 |
| 739 |
PAIN IN EXTREMITY |
310 |
0.0011 |
| 740 |
WEIGHT FLUCTUATION |
11 |
0.0011 |
| 741 |
CARDIAC FAILURE |
84 |
0.0010 |
| 742 |
RENAL PAIN |
11 |
0.0010 |
| 743 |
BACK PAIN |
241 |
0.0010 |
| 744 |
GENERAL PHYSICAL HEALTH DETERIORATION |
120 |
0.0010 |
| 745 |
TASTE DISORDER |
21 |
0.0010 |
| 746 |
DERMATITIS ALLERGIC |
13 |
0.0010 |
| 747 |
DIZZINESS |
514 |
0.0010 |
| 748 |
LUNG INFECTION |
16 |
0.0010 |
| 749 |
PULMONARY OEDEMA |
46 |
0.0010 |
| 750 |
FEELING ABNORMAL |
245 |
0.0010 |
| 751 |
HYPERGLYCAEMIA |
37 |
0.0010 |
| 752 |
BLOOD UREA INCREASED |
17 |
0.0010 |
| 753 |
DELIRIUM |
35 |
0.0010 |
| 754 |
NEUTROPHIL COUNT DECREASED |
41 |
0.0010 |
| 755 |
DISCOMFORT |
61 |
0.0010 |
| 756 |
GASTRIC ULCER |
19 |
0.0010 |
| 757 |
FATIGUE |
777 |
0.0010 |
| 758 |
DEPRESSION |
227 |
0.0010 |
| 759 |
GASTRITIS |
26 |
0.0010 |
| 760 |
TOXIC EPIDERMAL NECROLYSIS |
15 |
0.0010 |
| 761 |
TOOTH INFECTION |
13 |
0.0010 |
| 762 |
TOOTH ABSCESS |
10 |
0.0010 |
| 763 |
BLOOD CALCIUM DECREASED |
11 |
0.0010 |
| 764 |
CARDIOGENIC SHOCK |
14 |
0.0010 |
| 765 |
BLOOD PRESSURE SYSTOLIC INCREASED |
19 |
0.0010 |
| 766 |
MYELODYSPLASTIC SYNDROME |
14 |
0.0010 |
| 767 |
BLOOD PRESSURE ABNORMAL |
19 |
0.0010 |
| 768 |
CHOLECYSTITIS |
11 |
0.0009 |
| 769 |
FOETAL EXPOSURE DURING PREGNANCY |
75 |
0.0009 |
| 770 |
SEASONAL ALLERGY |
13 |
0.0009 |
| 771 |
EYE SWELLING |
34 |
0.0009 |
| 772 |
CYSTITIS |
29 |
0.0009 |
| 773 |
WHEEZING |
54 |
0.0009 |
| 774 |
HYPOTHYROIDISM |
29 |
0.0009 |
| 775 |
PHOTOPHOBIA |
17 |
0.0009 |
| 776 |
ABORTION SPONTANEOUS |
36 |
0.0009 |
| 777 |
OCULAR DISCOMFORT |
10 |
0.0009 |
| 778 |
BLOOD CREATININE INCREASED |
58 |
0.0009 |
| 779 |
SINUS CONGESTION |
12 |
0.0009 |
| 780 |
GAIT DISTURBANCE |
169 |
0.0009 |
| 781 |
PRURITUS GENERALISED |
19 |
0.0009 |
| 782 |
PRODUCT AVAILABILITY ISSUE |
20 |
0.0009 |
| 783 |
SCAR |
15 |
0.0009 |
| 784 |
HEADACHE |
548 |
0.0009 |
| 785 |
TOXICITY TO VARIOUS AGENTS |
146 |
0.0009 |
| 786 |
SWELLING FACE |
56 |
0.0009 |
| 787 |
LOCAL SWELLING |
15 |
0.0009 |
| 788 |
HAEMATOCRIT DECREASED |
17 |
0.0009 |
| 789 |
CRYING |
31 |
0.0009 |
| 790 |
MUSCULOSKELETAL CHEST PAIN |
13 |
0.0008 |
| 791 |
ACCIDENT |
10 |
0.0008 |
| 792 |
VERTIGO |
51 |
0.0008 |
| 793 |
MYELOSUPPRESSION |
30 |
0.0008 |
| 794 |
UNEVALUABLE EVENT |
63 |
0.0008 |
| 795 |
BRAIN FOG |
13 |
0.0008 |
| 796 |
HYPERTHYROIDISM |
12 |
0.0008 |
| 797 |
NO THERAPEUTIC RESPONSE |
10 |
0.0008 |
| 798 |
RHINORRHOEA |
53 |
0.0008 |
| 799 |
CHILLS |
96 |
0.0008 |
| 800 |
ASCITES |
24 |
0.0008 |
| 801 |
RENAL DISORDER |
38 |
0.0008 |
| 802 |
HYPOACUSIS |
35 |
0.0008 |
| 803 |
MULTI-ORGAN FAILURE |
14 |
0.0008 |
| 804 |
HEPATIC FUNCTION ABNORMAL |
30 |
0.0008 |
| 805 |
MYALGIA |
135 |
0.0008 |
| 806 |
BRAIN OEDEMA |
10 |
0.0008 |
| 807 |
CARPAL TUNNEL SYNDROME |
11 |
0.0008 |
| 808 |
PHARYNGEAL OEDEMA |
12 |
0.0008 |
| 809 |
RIB FRACTURE |
16 |
0.0008 |
| 810 |
LACTIC ACIDOSIS |
25 |
0.0008 |
| 811 |
DIPLOPIA |
20 |
0.0008 |
| 812 |
FLUSHING |
78 |
0.0008 |
| 813 |
PNEUMONIA ASPIRATION |
19 |
0.0008 |
| 814 |
MUSCULOSKELETAL DISCOMFORT |
13 |
0.0008 |
| 815 |
SEIZURE |
86 |
0.0007 |
| 816 |
DRY EYE |
37 |
0.0007 |
| 817 |
FOOT FRACTURE |
14 |
0.0007 |
| 818 |
PANCREATITIS |
39 |
0.0007 |
| 819 |
INJURY ASSOCIATED WITH DEVICE |
15 |
0.0007 |
| 820 |
CLOSTRIDIUM DIFFICILE INFECTION |
16 |
0.0007 |
| 821 |
COUGH |
205 |
0.0007 |
| 822 |
POST PROCEDURAL COMPLICATION |
14 |
0.0007 |
| 823 |
BONE PAIN |
42 |
0.0007 |
| 824 |
PRODUCTIVE COUGH |
34 |
0.0007 |
| 825 |
TENDONITIS |
11 |
0.0007 |
| 826 |
FEBRILE NEUTROPENIA |
47 |
0.0007 |
| 827 |
ECZEMA |
37 |
0.0007 |
| 828 |
DYSPEPSIA |
69 |
0.0007 |
| 829 |
INJECTION SITE HAEMORRHAGE |
56 |
0.0007 |
| 830 |
HEAD INJURY |
22 |
0.0007 |
| 831 |
DYSPNOEA |
391 |
0.0007 |
| 832 |
ABDOMINAL DISTENSION |
72 |
0.0007 |
| 833 |
INJURY |
48 |
0.0007 |
| 834 |
LYMPHOCYTE COUNT DECREASED |
12 |
0.0007 |
| 835 |
CARDIAC ARREST |
56 |
0.0007 |
| 836 |
FEELING HOT |
41 |
0.0007 |
| 837 |
ASTHENIA |
251 |
0.0007 |
| 838 |
THERAPEUTIC RESPONSE SHORTENED |
22 |
0.0007 |
| 839 |
HYPERSOMNIA |
19 |
0.0007 |
| 840 |
LIP SWELLING |
22 |
0.0007 |
| 841 |
ATRIAL FIBRILLATION |
64 |
0.0007 |
| 842 |
SUICIDAL IDEATION |
60 |
0.0007 |
| 843 |
MEMORY IMPAIRMENT |
90 |
0.0007 |
| 844 |
DYSSTASIA |
19 |
0.0007 |
| 845 |
SKIN CANCER |
14 |
0.0006 |
| 846 |
ROAD TRAFFIC ACCIDENT |
27 |
0.0006 |
| 847 |
PRODUCT ADMINISTRATION ERROR |
13 |
0.0006 |
| 848 |
FEEDING DISORDER |
13 |
0.0006 |
| 849 |
OXYGEN SATURATION DECREASED |
36 |
0.0006 |
| 850 |
HEART RATE INCREASED |
63 |
0.0006 |
| 851 |
BLOOD POTASSIUM DECREASED |
19 |
0.0006 |
| 852 |
OEDEMA PERIPHERAL |
77 |
0.0006 |
| 853 |
NASAL CONGESTION |
37 |
0.0006 |
| 854 |
RED BLOOD CELL COUNT DECREASED |
18 |
0.0006 |
| 855 |
RESPIRATORY TRACT CONGESTION |
10 |
0.0006 |
| 856 |
PLATELET COUNT DECREASED |
67 |
0.0006 |
| 857 |
METABOLIC ACIDOSIS |
20 |
0.0006 |
| 858 |
MUSCLE TIGHTNESS |
10 |
0.0006 |
| 859 |
GASTRIC DISORDER |
21 |
0.0006 |
| 860 |
GENERALISED TONIC-CLONIC SEIZURE |
10 |
0.0006 |
| 861 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
15 |
0.0006 |
| 862 |
BONE DISORDER |
11 |
0.0006 |
| 863 |
UPPER LIMB FRACTURE |
12 |
0.0006 |
| 864 |
MOVEMENT DISORDER |
19 |
0.0006 |
| 865 |
BLOOD PRESSURE DECREASED |
39 |
0.0006 |
| 866 |
TREATMENT NONCOMPLIANCE |
32 |
0.0006 |
| 867 |
SNEEZING |
13 |
0.0006 |
| 868 |
HEART RATE IRREGULAR |
13 |
0.0006 |
| 869 |
NEOPLASM PROGRESSION |
20 |
0.0006 |
| 870 |
CARDIO-RESPIRATORY ARREST |
24 |
0.0006 |
| 871 |
DEAFNESS |
15 |
0.0006 |
| 872 |
GASTROOESOPHAGEAL REFLUX DISEASE |
46 |
0.0006 |
| 873 |
COLD SWEAT |
10 |
0.0006 |
| 874 |
ABASIA |
14 |
0.0006 |
| 875 |
WEIGHT DECREASED |
157 |
0.0006 |
| 876 |
GASTROINTESTINAL HAEMORRHAGE |
47 |
0.0006 |
| 877 |
HYPOAESTHESIA |
84 |
0.0006 |
| 878 |
BLOOD BILIRUBIN INCREASED |
15 |
0.0006 |
| 879 |
PALLOR |
15 |
0.0006 |
| 880 |
PRODUCT PRESCRIBING ERROR |
13 |
0.0005 |
| 881 |
HAEMATOMA |
14 |
0.0005 |
| 882 |
DEHYDRATION |
72 |
0.0005 |
| 883 |
MENTAL IMPAIRMENT |
13 |
0.0005 |
| 884 |
FLUID RETENTION |
27 |
0.0005 |
| 885 |
DECREASED APPETITE |
120 |
0.0005 |
| 886 |
CARDIAC DISORDER |
48 |
0.0005 |
| 887 |
SWOLLEN TONGUE |
16 |
0.0005 |
| 888 |
EPISTAXIS |
38 |
0.0005 |
| 889 |
HAEMATOCHEZIA |
28 |
0.0005 |
| 890 |
OCULAR HYPERAEMIA |
24 |
0.0005 |
| 891 |
DRUG INTERACTION |
78 |
0.0005 |
| 892 |
COMA |
23 |
0.0005 |
| 893 |
FREQUENT BOWEL MOVEMENTS |
13 |
0.0005 |
| 894 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
25 |
0.0005 |
| 895 |
AMNESIA |
31 |
0.0005 |
| 896 |
PARAESTHESIA |
74 |
0.0005 |
| 897 |
VISUAL IMPAIRMENT |
58 |
0.0005 |
| 898 |
ANAPHYLACTIC SHOCK |
12 |
0.0005 |
| 899 |
FALL |
152 |
0.0005 |
| 900 |
DEPRESSED MOOD |
24 |
0.0005 |
| 901 |
NO ADVERSE EVENT |
82 |
0.0005 |
| 902 |
CONFUSIONAL STATE |
73 |
0.0005 |
| 903 |
IRRITABILITY |
27 |
0.0004 |
| 904 |
ACNE |
34 |
0.0004 |
| 905 |
EYE PRURITUS |
15 |
0.0004 |
| 906 |
PRODUCT STORAGE ERROR |
39 |
0.0004 |
| 907 |
PANCREATITIS ACUTE |
10 |
0.0004 |
| 908 |
CHROMATURIA |
10 |
0.0004 |
| 909 |
NERVOUSNESS |
23 |
0.0004 |
| 910 |
HYPERHIDROSIS |
56 |
0.0004 |
| 911 |
ASTHMA |
49 |
0.0004 |
| 912 |
DRY MOUTH |
35 |
0.0004 |
| 913 |
FEELING COLD |
12 |
0.0004 |
| 914 |
APHASIA |
13 |
0.0004 |
| 915 |
COGNITIVE DISORDER |
20 |
0.0004 |
| 916 |
HAEMORRHAGE |
44 |
0.0004 |
| 917 |
INTERNATIONAL NORMALISED RATIO INCREASED |
12 |
0.0004 |
| 918 |
NEOPLASM MALIGNANT |
28 |
0.0004 |
| 919 |
SKIN IRRITATION |
19 |
0.0004 |
| 920 |
HAEMATURIA |
14 |
0.0004 |
| 921 |
DYSURIA |
15 |
0.0004 |
| 922 |
DRUG DEPENDENCE |
65 |
0.0004 |
| 923 |
COLITIS ULCERATIVE |
18 |
0.0004 |
| 924 |
DEATH |
346 |
0.0004 |
| 925 |
RECTAL HAEMORRHAGE |
17 |
0.0004 |
| 926 |
HAEMOPTYSIS |
11 |
0.0004 |
| 927 |
CARDIOVASCULAR DISORDER |
10 |
0.0004 |
| 928 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
69 |
0.0004 |
| 929 |
ANXIETY |
108 |
0.0004 |
| 930 |
RENAL FAILURE ACUTE |
16 |
0.0004 |
| 931 |
DYSPHONIA |
22 |
0.0004 |
| 932 |
MOOD ALTERED |
10 |
0.0004 |
| 933 |
CEREBRAL HAEMORRHAGE |
13 |
0.0004 |
| 934 |
TRANSIENT ISCHAEMIC ATTACK |
12 |
0.0004 |
| 935 |
MUSCLE SPASMS |
65 |
0.0004 |
| 936 |
ANGINA PECTORIS |
10 |
0.0003 |
| 937 |
SOMNOLENCE |
70 |
0.0003 |
| 938 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
10 |
0.0003 |
| 939 |
CHEST DISCOMFORT |
34 |
0.0003 |
| 940 |
SKIN EXFOLIATION |
28 |
0.0003 |
| 941 |
VISUAL ACUITY REDUCED |
11 |
0.0003 |
| 942 |
LETHARGY |
19 |
0.0003 |
| 943 |
DISORIENTATION |
13 |
0.0003 |
| 944 |
TINNITUS |
15 |
0.0003 |
| 945 |
DERMATITIS ATOPIC |
17 |
0.0003 |
| 946 |
BRADYCARDIA |
17 |
0.0003 |
| 947 |
INTESTINAL OBSTRUCTION |
12 |
0.0003 |
| 948 |
ARRHYTHMIA |
15 |
0.0003 |
| 949 |
PRODUCT QUALITY ISSUE |
43 |
0.0003 |
| 950 |
CHOLELITHIASIS |
10 |
0.0003 |
| 951 |
EYE DISORDER |
10 |
0.0003 |
| 952 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
12 |
0.0003 |
| 953 |
MENTAL DISORDER |
13 |
0.0003 |
| 954 |
HOSPITALISATION |
45 |
0.0003 |
| 955 |
DYSARTHRIA |
11 |
0.0003 |
| 956 |
LUNG NEOPLASM MALIGNANT |
12 |
0.0003 |
| 957 |
SURGERY |
17 |
0.0003 |
| 958 |
BALANCE DISORDER |
25 |
0.0003 |
| 959 |
WITHDRAWAL SYNDROME |
12 |
0.0003 |
| 960 |
THERAPY INTERRUPTED |
20 |
0.0003 |
| 961 |
BREAST CANCER |
26 |
0.0003 |
| 962 |
THROAT IRRITATION |
12 |
0.0003 |
| 963 |
SPEECH DISORDER |
14 |
0.0003 |
| 964 |
TREMOR |
44 |
0.0003 |
| 965 |
PALPITATIONS |
31 |
0.0003 |
| 966 |
DYSPHAGIA |
25 |
0.0003 |
| 967 |
NEUROPATHY PERIPHERAL |
25 |
0.0003 |
| 968 |
DRY SKIN |
34 |
0.0003 |
| 969 |
CEREBROVASCULAR ACCIDENT |
43 |
0.0003 |
| 970 |
CONSTIPATION |
55 |
0.0003 |
| 971 |
HOT FLUSH |
19 |
0.0003 |
| 972 |
ACCIDENTAL OVERDOSE |
9 |
0.0002 |
| 973 |
VISION BLURRED |
33 |
0.0002 |
| 974 |
EYE PAIN |
13 |
0.0002 |
| 975 |
FLATULENCE |
13 |
0.0002 |
| 976 |
BLOOD GLUCOSE INCREASED |
40 |
0.0002 |
| 977 |
BLOOD GLUCOSE DECREASED |
10 |
0.0002 |
| 978 |
EYE IRRITATION |
11 |
0.0002 |
| 979 |
AGITATION |
14 |
0.0002 |
| 980 |
INCORRECT DOSE ADMINISTERED |
36 |
0.0002 |
| 981 |
HALLUCINATION |
11 |
0.0001 |
| 982 |
EMOTIONAL DISTRESS |
17 |
0.0001 |
| 983 |
SKIN BURNING SENSATION |
10 |
0.0001 |
| 984 |
CARDIAC FAILURE CONGESTIVE |
11 |
0.0001 |
| 985 |
DYSGEUSIA |
10 |
0.0001 |
| 986 |
MALIGNANT NEOPLASM PROGRESSION |
13 |
0.0001 |
| 987 |
DRUG DOSE OMISSION |
16 |
0.0001 |
| 988 |
OVERDOSE |
20 |
0.0001 |
| 989 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
18 |
0.0001 |